Table 4. Number of cancers diagnosed in a cohort of 100 000 women aged 20–26 years (inclusive) under different cancer progression scenarios.
| |
|
Invited from age 25 years |
||
|---|---|---|---|---|
| Age group (years) | Invited from age 20 years | Cancer rates (scenario 1) | Case–control (scenario 2) | CIN3 progression (scenario 3) |
|
Cancers (all) | ||||
| 20–24 | 20.0 | 14.7 | 14.0 | 16.7 |
| 25–26 | 30.0 | 58.3 | 36.0 | 46.9 |
| Sum |
50.0 |
73.1 |
50.0 |
63.7 |
|
Cancers (stage IA) | ||||
| 20–24 | 8.0 | 0.0 | 0.0 | 0.0 |
| 25–26 | 14.6 | 42.6 | 18.6 | 26.8 |
| Sum |
22.6 |
42.6 |
18.6 |
26.8 |
|
Cancers (stage IB+) | ||||
| 20–24 | 12.0 | 14.7 | 14.0 | 16.7 |
| 25–26 | 15.4 | 15.7 | 17.4 | 20.2 |
| Sum | 27.4 | 30.4 | 31.4 | 36.9 |